Uhlenhuth E H, DeWit H, Balter M B, Johanson C E, Mellinger G D
Department of Psychiatry, University of New Mexico School of Medicine, Albuquerque 87131.
J Clin Psychopharmacol. 1988 Jun;8(3):161-7.
Despite a sharp decline in the prescription of benzodiazepines during the past decade, reservations about their use have continued to escalate. This article presents converging data from three diverse sources: national survey data from consumers, laboratory data on the drug preferences of normal subjects, and a controlled clinical study of long-term diazepam treatment and withdrawal. These data suggest that (1) the risks of overuse, dependence, and addiction with benzodiazepines are low in relation to the massive exposure in our society; (2) benzodiazepine addiction can occur when doses within the clinical range are taken regularly over about 6 months; (3) many patients continue to derive benefit from long-term treatment with benzodiazepines; and (4) attitudes strongly against the use of these drugs may be depriving many anxious patients of appropriate treatment.
尽管在过去十年中苯二氮䓬类药物的处方量急剧下降,但对其使用的保留意见仍在不断升级。本文呈现了来自三个不同来源的趋同数据:消费者的全国性调查数据、正常受试者药物偏好的实验室数据,以及一项关于长期使用地西泮治疗和戒断的对照临床研究。这些数据表明:(1)相对于我们社会中的大量使用情况,苯二氮䓬类药物过度使用、依赖和成瘾的风险较低;(2)当在临床范围内的剂量连续服用约6个月时,可能会发生苯二氮䓬类药物成瘾;(3)许多患者继续从苯二氮䓬类药物的长期治疗中获益;(4)强烈反对使用这些药物的态度可能使许多焦虑患者得不到适当治疗。